Abiraterone methyl ether

SL-2787

Abiraterone methyl ether, >98%

CAS No. : [1470276-23-3]

IUPAC Name : 3-((3S,8R,9S,10R,13S,14S)-3-Methoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
100MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
250MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : Abiraterone methyl ether is an impurity of Abiraterone, which is a potent, selective, and irreversible CYP17 inhibitor, is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.

References : Attard G. et al.: J. Clin. Oncol. 26(28), 4563-4571. 2008; Richards J. et al.: Cancer Res. 72(9), 2176-2182, 2012; Stein M. N. et al.: Asian J. Androl. 16(3), 387-400, 2014; Li R. et al.: Clin Cancer Res. 18(13), 3571-3579, 2012; Kumar S. V. et al. V. Biomed Chromatogr., 27(2), 203-207, 2013.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.